Skip to content
Politically.com Search all
Menu

2025 · 3rd Quarter (July 1 - Sep 30)

THE UNITED STATES PHARMACOPEIAL CONVENTION

Filed by THE UNITED STATES PHARMACOPEIAL CONVENTION.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
3rd Quarter - Report
Posted
Oct 20, 2025
Income
Not reported
Expenses
$80,000.00
Filing UUID
6aec8f0d-e49d-4f51-84eb-46a37149499b
Termination date
Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain resilience. Issues regarding drug shortages and pharmaceutical supply chain resilience.

Literal federal measure citations: S. 1784, H.R. 4191

BUD · Budget/Appropriations

H.R. 5304, S.2587 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026: Provisions related to pharmaceutical supply chain resilience.

Literal federal measure citations: H.R. 5304, S.2587

DEF · Defense

S. 2296 - National Defense Authorization Act for Fiscal Year 2026: Provisions regarding medicine supply chain.

Literal federal measure citations: S. 2296

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.